Moneta Group Investment Advisors LLC decreased its holdings in shares of UnitedHealth Group Inc (NYSE:UNH) by 60.6% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,702 shares of the healthcare conglomerate’s stock after selling 4,161 shares during the quarter. Moneta Group Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,614,000 as of its most recent SEC filing.
Several other institutional investors have also added to or reduced their stakes in UNH. Northern Trust Corp increased its holdings in shares of UnitedHealth Group by 0.4% during the 2nd quarter. Northern Trust Corp now owns 12,111,540 shares of the healthcare conglomerate’s stock worth $2,955,336,000 after buying an additional 53,710 shares during the last quarter. Geode Capital Management LLC increased its holdings in UnitedHealth Group by 9.1% in the 4th quarter. Geode Capital Management LLC now owns 11,593,401 shares of the healthcare conglomerate’s stock valued at $2,882,988,000 after purchasing an additional 965,763 shares during the last quarter. Janus Henderson Group PLC raised its position in UnitedHealth Group by 16.7% in the second quarter. Janus Henderson Group PLC now owns 6,448,289 shares of the healthcare conglomerate’s stock valued at $1,573,438,000 after purchasing an additional 922,290 shares during the period. Sanders Capital LLC raised its position in UnitedHealth Group by 50.2% in the second quarter. Sanders Capital LLC now owns 4,626,666 shares of the healthcare conglomerate’s stock valued at $1,255,689,000 after purchasing an additional 1,546,140 shares during the period. Finally, Caisse DE Depot ET Placement DU Quebec lifted its stake in UnitedHealth Group by 12.8% during the second quarter. Caisse DE Depot ET Placement DU Quebec now owns 2,595,484 shares of the healthcare conglomerate’s stock worth $633,324,000 after purchasing an additional 295,000 shares in the last quarter. 86.04% of the stock is owned by institutional investors and hedge funds.
Several research firms recently issued reports on UNH. Morgan Stanley boosted their price objective on UnitedHealth Group from $285.00 to $298.00 and gave the company an “overweight” rating in a report on Friday, July 12th. Credit Suisse Group set a $293.00 target price on UnitedHealth Group and gave the company a “buy” rating in a report on Thursday, August 29th. Oppenheimer set a $312.00 target price on UnitedHealth Group and gave the company a “buy” rating in a research report on Friday, July 19th. Royal Bank of Canada set a $311.00 price target on shares of UnitedHealth Group and gave the stock a “buy” rating in a research note on Friday, July 19th. Finally, Cleveland Research reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Monday, July 15th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the company’s stock. UnitedHealth Group currently has a consensus rating of “Buy” and a consensus target price of $294.11.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.46 by $0.14. The company had revenue of $60.60 billion for the quarter, compared to the consensus estimate of $60.59 billion. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. UnitedHealth Group’s revenue was up 8.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.14 EPS. Equities analysts expect that UnitedHealth Group Inc will post 14.84 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th will be given a dividend of $1.08 per share. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date of this dividend is Friday, September 13th. UnitedHealth Group’s dividend payout ratio is presently 33.54%.
In other news, Director Timothy Patrick Flynn bought 2,000 shares of the stock in a transaction that occurred on Wednesday, August 28th. The stock was purchased at an average price of $227.55 per share, for a total transaction of $455,100.00. Following the completion of the purchase, the director now owns 5,524 shares in the company, valued at approximately $1,256,986.20. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director William C. Ballard, Jr. sold 12,000 shares of the stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $255.31, for a total value of $3,063,720.00. Following the completion of the transaction, the director now directly owns 61,309 shares in the company, valued at approximately $15,652,800.79. The disclosure for this sale can be found here. Insiders have sold 19,000 shares of company stock worth $4,758,720 over the last 90 days. Insiders own 0.82% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Read More: Are all No-Load Funds Equal?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.